| abstract |
The present invention has the formula: [Chemical 1] [Where: A is OR 1 , NR 1 R 2 or R 1 , wherein R 1 and R 2 are hydrogen, C 1-6 alkyl, aryl, heteroaryl, arylalkyl or heteroarylalkyl; R 1 and R 2 together with the nitrogen atom to which they are attached form a 5 or 6 membered saturated cyclic device; B is C (O) R 3 , wherein R 3 is C 1-6 alkyl, aryl, heteroaryl, arylalkyl or heteroarylalkyl; C is C 1-6 alkyl, aryl, heteroaryl or heterocyclyl; D is a saturated or unsaturated optionally substituted 5-membered heterocyclic ring; E is hydrogen or C 1-6 alkyl; F is hydrogen, C 1-6 alkyl, aryl or heteroaryl; G is hydrogen, C 1-6 alkyl, heterocyclylalkyl, arylalkyl or heteroarylalkyl] Or a salt or solvate thereof, a method for producing the same, and a method for using the same in the treatment of HCV. |